grant

Exploiting Tumour Ablation Histotripsy to Augment anti-cancer Immunotherapy in Hepatocellular Carcinoma

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Get Agency plan to apply$29.99/mo · 7-day free trial · pipeline · alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Tumour ablative procedures, such as microwave ablation and cryoablation, offer localised tumour control for hepatocellular carcinoma (HCC) but are limited by damage to the surrounding cirrhotic background liver. Histotripsy is a new non-invasive and highly targeted tumour ablation procedure under development by Histosonics, which stands to improve…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →

Explore more

📍 More grants in United Kingdom🏷 More UKRI opportunities🏷 More UK Research opportunities🏷 More Grant opportunities🏢 All ukri_grants opportunities
Exploiting Tumour Ablation Histotripsy to Augment anti-cancer Immunotherapy in Hepatocellular Carcinoma — UKRI | United | Dev Procure